GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OK Biotech Co Ltd (TPE:4155) » Definitions » Ending Cash Position

OK Biotech Co (TPE:4155) Ending Cash Position : NT$221 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is OK Biotech Co Ending Cash Position?

OK Biotech Co's Ending Cash Position for the quarter that ended in Mar. 2024 was NT$221 Mil.

OK Biotech Co's quarterly Ending Cash Position declined from Sep. 2023 (NT$508 Mil) to Dec. 2023 (NT$323 Mil) and declined from Dec. 2023 (NT$323 Mil) to Mar. 2024 (NT$221 Mil).

OK Biotech Co's annual Ending Cash Position declined from Dec. 2021 (NT$600 Mil) to Dec. 2022 (NT$596 Mil) and declined from Dec. 2022 (NT$596 Mil) to Dec. 2023 (NT$323 Mil).


OK Biotech Co Ending Cash Position Historical Data

The historical data trend for OK Biotech Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OK Biotech Co Ending Cash Position Chart

OK Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 332.31 566.72 599.85 596.42 323.03

OK Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 291.77 300.07 507.86 323.03 221.07

OK Biotech Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

OK Biotech Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=596.419+-273.386
=323

OK Biotech Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=323.033+-101.964
=221


OK Biotech Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of OK Biotech Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


OK Biotech Co (TPE:4155) Business Description

Traded in Other Exchanges
N/A
Address
No.91, Gongdao 5th Road, Section 2, Hsinchu, TWN, 30070
OK Biotech Co Ltd is engaged in the manufacturing of electronic materials and medical devices. The products of the company include Portable Nebulizer, Blood Glucose Meter, Glucometer, Blood Sugar Meter, Blood Glucose Test Strips, and others.

OK Biotech Co (TPE:4155) Headlines

No Headlines